This page shows the latest Alexion Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Earlier this month, Alexion Pharmaceuticals appointed its first chief diversity officer, with Uzair Qadeer taking on the role after serving as head of enterprise partnerships at the company.
It already has a rare and complex disease collaboration with Alexion Pharmaceuticals - which it describes as a "model for how industry and academia can better work together to bring health innovations
Alexion’s Soliris has become the first drug to pass through NICE’s new highly specialised technology process. ... No quick solution. Jon Beauchamp, business unit leader PNH/aHUS at Alexion Pharmaceuticals, told PME: “It's certainly been a very
From left: New Haven Mayor John DeStefano, Sen. Richard Blumenthal, Governor Dan Malloy, Alexion CEO Leonard Bell, Rep. ... Alexion Pharmaceuticals has broken ground on the site for its new global headquarters in New Haven, Connecticut.
PDLs litigation with Alexion Pharmaceuticals. ... Link is chairman of Alexion, while PDL has filed a patent infringement lawsuit against the company.
More from news
Approximately 0 fully matching, plus 5 partially matching documents found.
144. Moderna Therapeutics/ Alexion Pharmaceuticals. Exclusive discovery and development. Messenger RNA (mRNA) therapeutics in rare diseases for 10 product options. ... 100. Cancer Prevention Pharmaceuticals/ Zeria Tillotts Pharma. Exclusive licensing
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Prior to CRISPR, he worked as head of translational medicine at Alexion Pharmaceuticals, and also served as chief medical officer of Taligen Therapeutics. ... Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined
He joins the company from Aegerion Pharmaceuticals. Amryt Pharma, a company focused on treatments for rare and orphan diseases, has appointed Jordi Casals as the biopharma’s head of Europe. ... Prior to this, he worked for eight years at Alexion
Judith Reinsdorf recently worked at Johnson Controls. Alexion Pharmaceuticals has appointed Judith Reinsdorf to its board of directors following her role as executive vice president and general counsel of Johnson Controls. ... David Brennan, chairman of
Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel. ... Meanwhile, Valles-Sukkar arrives
Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from
More from appointments
Approximately 1 fully matching, plus 8 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...